These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37279114)

  • 1. Pharmacokinetics and drug-likeness of anti-cancer traditional Chinese medicine: molecular docking and molecular dynamics simulation study.
    Khan K; Albalawi K; Abbas MN; Burki S; Musad Saleh EA; Al Mouslem A; Alsaiari AA; A Zaki ME; Khan AU; Alotaibi G; Jalal K
    J Biomol Struct Dyn; 2024 Apr; 42(7):3295-3306. PubMed ID: 37279114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacoinformatics and molecular dynamics simulation-based phytochemical screening of neem plant (Azadiractha indica) against human cancer by targeting MCM7 protein.
    Ahammad F; Alam R; Mahmud R; Akhter S; Talukder EK; Tonmoy AM; Fahim S; Al-Ghamdi K; Samad A; Qadri I
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33834183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-Throughput Screening and Molecular Dynamics Simulation of Natural Products for the Identification of Anticancer Agents against MCM7 Protein.
    Zhang X; Chen H; Lin H; Wen R; Yang F
    Appl Bionics Biomech; 2022; 2022():8308192. PubMed ID: 36157125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioinformatics approaches identified dasatinib and bortezomib inhibit the activity of MCM7 protein as a potential treatment against human cancer.
    Samad A; Huq MA; Rahman MS
    Sci Rep; 2022 Jan; 12(1):1539. PubMed ID: 35087187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational Screening of Natural Compounds for Identification of Potential Anti-Cancer Agents Targeting MCM7 Protein.
    Alshahrani MY; Alshahrani KM; Tasleem M; Akeel A; Almeleebia TM; Ahmad I; Asiri M; Alshahrani NA; Alabdallah NM; Saeed M
    Molecules; 2021 Sep; 26(19):. PubMed ID: 34641424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
    Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
    Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational Investigation of 1, 3, 4 Oxadiazole Derivatives as Lead Inhibitors of VEGFR 2 in Comparison with EGFR: Density Functional Theory, Molecular Docking and Molecular Dynamics Simulation Studies.
    Bilal MS; Ejaz SA; Zargar S; Akhtar N; Wani TA; Riaz N; Aborode AT; Siddique F; Altwaijry N; Alkahtani HM; Umar HI
    Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virtual screening, pharmacokinetics, molecular dynamics and binding free energy analysis for small natural molecules against cyclin-dependent kinase 5 for Alzheimer's disease.
    Shukla R; Singh TR
    J Biomol Struct Dyn; 2020 Jan; 38(1):248-262. PubMed ID: 30688165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational screening and molecular docking of compounds from Traditional Chinese Medicine (TCM) by targeting DNA topoisomerase I to design potential anticancer drugs.
    Shimu MSS
    PLoS One; 2024; 19(9):e0310364. PubMed ID: 39264927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A combination strategy of structure-based virtual screening, MM-GBSA, cross docking, molecular dynamics and metadynamics simulations used to investigate natural compounds as potent and specific inhibitors of tumor linked human carbonic anhydrase IX.
    Chahal V; Kakkar R
    J Biomol Struct Dyn; 2023; 41(12):5465-5480. PubMed ID: 35735269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Glutaminase by Natural Compounds: Structure-Based Virtual Screening and Molecular Dynamics Simulation Approach to Suppress Cancer Progression.
    Tabrez S; Zughaibi TA; Hoque M; Suhail M; Khan MI; Khan AU
    Molecules; 2022 Aug; 27(15):. PubMed ID: 35956989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying novel therapeutic inhibitors to target FMS-like tyrosine kinase-3 (FLT3) against acute myeloid leukemia: a molecular docking, molecular dynamics, and DFT study.
    Islam MR; Osman OI; Hassan WMI
    J Biomol Struct Dyn; 2024; 42(1):82-100. PubMed ID: 36995071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring Lead-Like Molecules of Traditional Chinese Medicine for Treatment Quest against
    Basharat Z; Ahmed I; Alnasser SM; Meshal A; Waheed Y
    Biomed Res Int; 2024; 2024():9377016. PubMed ID: 39282570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular dynamics simulation for screening phytochemicals as α-amylase inhibitors from medicinal plants.
    Sharma P; Joshi T; Joshi T; Chandra S; Tamta S
    J Biomol Struct Dyn; 2021 Oct; 39(17):6524-6538. PubMed ID: 32748738
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of high-affinity inhibitors of pyruvate dehydrogenase kinase-3: towards therapeutic management of cancer.
    Mohammad T; Arif K; Alajmi MF; Hussain A; Islam A; Rehman MT; Hassan I
    J Biomol Struct Dyn; 2021 Feb; 39(2):586-594. PubMed ID: 31903847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of novel ligand targeting bromodomain-containing protein 4 (BRD4) for cancer drug discovery: complete pharmacophore approach.
    Shanmugam V; Muthukrishnan S
    J Biomol Struct Dyn; 2023; 41(23):14524-14539. PubMed ID: 36841551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of potent EGFR-TKD inhibitors from NPACT database through combined computational approaches.
    Mir SA; Muhammad A; Padhiary A; Ekka NJ; Baitharu I; Naik PK; Nayak B
    J Biomol Struct Dyn; 2023; 41(21):12063-12076. PubMed ID: 36695102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the New Inhibitors by Sulfadiazine and Modified Derivatives of α-D-glucopyranoside for White Spot Syndrome Virus Disease of Shrimp by In Silico: Quantum Calculations, Molecular Docking, ADMET and Molecular Dynamics Study.
    Kumer A; Chakma U; Rana MM; Chandro A; Akash S; Elseehy MM; Albogami S; El-Shehawi AM
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35744817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico investigation of potential TRAF6 inhibitor from traditional Chinese medicine against cancers.
    Chen KC; Lee WY; Chen HY; Chen CY
    Biomed Res Int; 2014; 2014():429486. PubMed ID: 25089269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of novel natural compound inhibitors targeting estrogen receptor α by an integrated virtual screening strategy.
    Yu E; Xu Y; Shi Y; Yu Q; Liu J; Xu L
    J Mol Model; 2019 Aug; 25(9):278. PubMed ID: 31463793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.